SCHEMBL28640313

SCHEMBL28640313

Cn1cc(-c2ccc(S(C)(=O)=O)cc2)c(-c2cccc3[nH]ncc23)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 5/20 0.59
BRAF P15056 5/20 0.58
METAP2 P50579 2/20 0.49
PIK3CD O00329 1/20 0.48
PIK3CB P42338 1/20 0.48
PIK3CG P48736 1/20 0.48
PRKDC P78527 1/20 0.48
RAF1 P04049 2/20 0.45
MAPK3 P27361 1/20 0.43
MAPK1 P28482 1/20 0.43
PTK6 Q13882 1/20 0.42
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
CREBBP Q92793 1/20 0.41
PTGS2 P35354 4/20 0.40
PTGS1 P23219 1/20 0.40
AURKA O14965 1/20 0.40
ROCK2 O75116 1/20 0.40
ERBB2 P04626 1/20 0.40
CSF1R P07333 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28924972 0.84 PIK3CA (0.60) PIK3CABRAFMETAP2PIK3CDPIK3CB
SCHEMBL28961950 0.81 BRAF (0.61) PIK3CABRAFMETAP2RAF1MAPK3
SCHEMBL7779486 0.75 PTGS2 (0.58) PTGS2PTGS1
SCHEMBL28640314 0.75 PIK3CA (0.52) PIK3CABRAFMETAP2PIK3CDPIK3CB
SCHEMBL561550 0.75 PIK3CA (0.75) PIK3CABRAFMETAP2PIK3CDPIK3CB
SCHEMBL2194222 0.75 PIK3CA (1.00) PIK3CABRAFMETAP2PIK3CDPIK3CB
SCHEMBL22886577 0.74 BRAF (0.57) PIK3CABRAFMETAP2CREBBPAURKA
SCHEMBL26715311 0.73 PIK3CA (0.57) PIK3CABRAFMETAP2PIK3CDPIK3CB
SCHEMBL28631160 0.73 BRAF (0.55) PIK3CABRAFMETAP2MAPK3MAPK1
SCHEMBL7777709 0.72 PTGS2 (0.53) BRAFMAPK3MAPK1PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106659765-B Use of dianhydrogalactitol and analogs or derivatives thereof for treating non-small cell lung cancer and ovarian cancer 德玛医药 2021-08-13 CN disclosed